JP7849377B2 - フェンアルキルアミン、並びにこれを作製及び使用する方法 - Google Patents
フェンアルキルアミン、並びにこれを作製及び使用する方法Info
- Publication number
- JP7849377B2 JP7849377B2 JP2023555630A JP2023555630A JP7849377B2 JP 7849377 B2 JP7849377 B2 JP 7849377B2 JP 2023555630 A JP2023555630 A JP 2023555630A JP 2023555630 A JP2023555630 A JP 2023555630A JP 7849377 B2 JP7849377 B2 JP 7849377B2
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- mixture
- dimethoxy
- equivalents
- stirred
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163160292P | 2021-03-12 | 2021-03-12 | |
| US63/160,292 | 2021-03-12 | ||
| PCT/US2022/020196 WO2022192781A1 (en) | 2021-03-12 | 2022-03-14 | Phenalkylamines and methods of making and using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024512425A JP2024512425A (ja) | 2024-03-19 |
| JP2024512425A5 JP2024512425A5 (https=) | 2025-03-24 |
| JP7849377B2 true JP7849377B2 (ja) | 2026-04-21 |
Family
ID=80999639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555630A Active JP7849377B2 (ja) | 2021-03-12 | 2022-03-14 | フェンアルキルアミン、並びにこれを作製及び使用する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240166618A1 (https=) |
| EP (1) | EP4305019A1 (https=) |
| JP (1) | JP7849377B2 (https=) |
| KR (1) | KR20240019063A (https=) |
| CN (1) | CN117642379A (https=) |
| AU (1) | AU2022234444A1 (https=) |
| BR (1) | BR112023018237A2 (https=) |
| CA (1) | CA3213289A1 (https=) |
| IL (1) | IL305834A (https=) |
| MX (1) | MX2023010711A (https=) |
| WO (1) | WO2022192781A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4460489A4 (en) * | 2022-01-04 | 2026-04-08 | Bright Minds Biosciences Inc | PHENETHYLAMINES AND THEIR PREPARATION PROCESSES |
| WO2023205116A1 (en) * | 2022-04-19 | 2023-10-26 | Gilgamesh Pharmaceuticals, Inc. | Pyridine derivatives for treating psychiatric disorders |
| AR130467A1 (es) * | 2022-09-12 | 2024-12-11 | Gilgamesh Pharmaceuticals Inc | Fenalquilaminas y métodos para fabricar y usar las mismas |
| WO2025085701A1 (en) * | 2023-10-18 | 2025-04-24 | Gilgamesh Pharmaceuticals, Inc. | Pyridine derivatives for treating psychiatric disorders |
| CN119827467B (zh) * | 2025-01-10 | 2026-03-24 | 中国科学技术大学 | 酰亚胺类化合物用于阿片类毒品的光激活荧光检测方法 |
| CN120271454B (zh) * | 2025-04-01 | 2026-01-06 | 衢州凯沃化工有限公司 | 一种光催化合成含七氟异丙基取代的苯胺化合物的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643310A1 (de) * | 1966-12-29 | 1971-06-03 | Dow Chemical Co | 4-Alkyl-2,5-dimethoxy-alpha-methyl-phenaethylamin und seine pharmakologisch vertraeglichen Salze |
| TW200744567A (en) * | 2005-09-23 | 2007-12-16 | Alcon Inc | Phenylethylamine analogs and their use for treating glaucoma |
-
2022
- 2022-03-14 JP JP2023555630A patent/JP7849377B2/ja active Active
- 2022-03-14 KR KR1020237034789A patent/KR20240019063A/ko active Pending
- 2022-03-14 CA CA3213289A patent/CA3213289A1/en active Pending
- 2022-03-14 WO PCT/US2022/020196 patent/WO2022192781A1/en not_active Ceased
- 2022-03-14 EP EP22714085.2A patent/EP4305019A1/en active Pending
- 2022-03-14 MX MX2023010711A patent/MX2023010711A/es unknown
- 2022-03-14 IL IL305834A patent/IL305834A/en unknown
- 2022-03-14 AU AU2022234444A patent/AU2022234444A1/en active Pending
- 2022-03-14 BR BR112023018237A patent/BR112023018237A2/pt unknown
- 2022-03-14 CN CN202280034218.1A patent/CN117642379A/zh active Pending
- 2022-03-14 US US18/281,127 patent/US20240166618A1/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| BLAAZER, Antoni R., et al.,ChemMedChem,2008年,Volume 3, Issue 9,p.1299-1309 |
| NELSON, D.L., et al.,Naunyn-Schmiedeberg’s Archives of Pharmacology,1999年,Vol.359,p.1-6 |
| STANDRIDGE, Robert T., et al.,Journal of Medicinal Chemistry,Vol. 23, Issue 2,1980年,p.154-162 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3213289A1 (en) | 2022-09-15 |
| JP2024512425A (ja) | 2024-03-19 |
| BR112023018237A2 (pt) | 2023-11-28 |
| MX2023010711A (es) | 2023-11-10 |
| WO2022192781A1 (en) | 2022-09-15 |
| EP4305019A1 (en) | 2024-01-17 |
| CN117642379A (zh) | 2024-03-01 |
| AU2022234444A1 (en) | 2023-09-28 |
| IL305834A (en) | 2023-11-01 |
| KR20240019063A (ko) | 2024-02-14 |
| US20240166618A1 (en) | 2024-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7849377B2 (ja) | フェンアルキルアミン、並びにこれを作製及び使用する方法 | |
| TWI843712B (zh) | K他命的前藥及其組成物及用途 | |
| CN114945566A (zh) | 作为钠通道调节剂的取代四氢呋喃 | |
| JP2022513959A (ja) | 大環状化合物及び疾患の処置におけるそれらの使用 | |
| CN106211770B (zh) | 作为γ‑分泌酶调节剂的色烯和1,1A,2,7B‑四氢环丙烷并[c]色烯吡啶并吡嗪二酮 | |
| JP2024516174A (ja) | 新規エルゴリン及び気分障害を処置する方法 | |
| SK1694A3 (en) | Pyrolidine derivatives, preparation thereof and drugs containing same | |
| TWI743088B (zh) | 作爲免疫調節劑的三並環化合物 | |
| WO2020007322A1 (zh) | 一种靶向降解bet蛋白的化合物及其应用 | |
| TW201427971A (zh) | 二氫吡唑gpr40調節劑 | |
| JP2005527602A (ja) | 新規なジアザビシクロノンエン | |
| US12428373B2 (en) | Dopamine D2 receptor ligands | |
| TW201730148A (zh) | 作為s1p調節劑的稠合(雜)環化合物 | |
| CN105330595A (zh) | 吡啶衍生物及其作为抗分支杆菌的应用 | |
| CN107406445B (zh) | 新颖环丙苯并呋喃基吡啶并吡嗪二酮类 | |
| JP2022551198A (ja) | Kv1.3カリウムシェーカーチャネル遮断薬としてのアリールメチレン複素環式化合物 | |
| HK1254800A1 (zh) | 2,3,4,5-四氢吡啶-6-胺衍生物 | |
| JP7033139B2 (ja) | 障害の治療のためのヒドロキシノルケタミン誘導体 | |
| US12428380B2 (en) | Compounds | |
| KR20260053507A (ko) | 화합물 | |
| CN107200725B (zh) | 稠杂环类衍生物、其制备方法及其在医药上的应用 | |
| HK40070790B (zh) | 氯胺酮的前药、其组合物和用途 | |
| JP2011231057A (ja) | セラミド産生促進剤 | |
| HK40033315B (zh) | 氯胺酮的前药、其组合物和用途 | |
| HK1242315A1 (en) | Novel cyclopropabenzofuranyl pyridopyrazinediones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250313 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250313 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250715 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20251015 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260115 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260310 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260409 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7849377 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |